n.成神经节细胞瘤；成神经节胶质神经瘤

Ganglioneuroblastoma is a rare type of neuroendocrine tumor that typically affects children.
这是一种罕见的神经内分泌肿瘤，通常影响儿童。
The diagnosis of ganglioneuroblastoma was confirmed through histopathological examination of the biopsy sample.
通过活检样本的病理学检查确认了神经节母细胞瘤的诊断。
Treatment for ganglioneuroblastoma often involves surgery, chemotherapy, and radiation therapy, depending on the stage of the cancer.
对于神经节母细胞瘤的治疗通常包括手术、化疗和放疗，具体取决于癌症的阶段。
Prognosis for patients with ganglioneuroblastoma can vary; some cases are low-risk, while others are high-risk and require aggressive management.
神经节母细胞瘤患者的预后差异很大，有些病例风险较低，而其他病例则需要积极管理。
Long-term follow-up is crucial for monitoring potential recurrence or progression of ganglioneuroblastoma after initial treatment.
初始治疗后的长期随访对于监测可能的复发或神经节母细胞瘤进展至关重要。
Symptoms of ganglioneuroblastoma may include abdominal pain, rapid weight gain, or the presence of a tumor mass.
神经节母细胞瘤的症状可能包括腹痛、体重快速增加或肿瘤肿块的存在。
Researchers continue to investigate new targeted therapies for ganglioneuroblastoma in an effort to improve patient outcomes.
研究人员仍在研究针对神经节母细胞瘤的新靶向疗法，以期改善患者结局。
Early detection of ganglioneuroblastoma through routine pediatric check-ups can lead to more effective treatment and better chances of survival.
通过常规的儿科体检早期发现神经节母细胞瘤，可以促进更有效的治疗并提高生存机会。
Supportive care, including emotional and nutritional counseling, is also an essential part of managing the side effects of ganglioneuroblastoma treatment.
支持性护理，包括情绪和营养咨询，也是管理神经节母细胞瘤治疗副作用的重要部分。
Despite advancements in treatment, understanding the genetic basis of ganglioneuroblastoma is still a key area of research to improve patient outcomes.
尽管治疗方法有所进步，但对神经节母细胞瘤的遗传基础的理解仍然是提高患者预后的重要研究领域。